Five v ten days' therapy with furazolidone for giardiasis

Area of Science:

• Pediatric Infectious Diseases
• Parasitology
• Clinical Pharmacology

Background:

• Giardiasis is a common intestinal infection in children.
• Previous uncontrolled studies suggested five days of furazolidone is effective.
• Optimal treatment duration for pediatric giardiasis requires further investigation.

Purpose of the Study:

• To compare the efficacy of five versus ten days of furazolidone treatment for giardiasis in children.
• To evaluate clinical and parasitological outcomes in pediatric patients with giardiasis.

Main Methods:

• Prospective, randomized study involving 22 children diagnosed with giardiasis.
• Patients were randomized to receive either a five-day or a ten-day course of furazolidone.
• Treatment efficacy was assessed based on clinical improvement and parasitological clearance.

Main Results:

• A ten-day furazolidone regimen achieved a 92% cure rate (11 of 12 patients).
• A five-day regimen resulted in only a 20% cure rate (2 of 10 patients).
• Five of eight patients who failed the five-day regimen were cured after re-treatment for ten days.

Conclusions:

• Furazolidone therapy for less than seven to ten days is not recommended for treating giardiasis in children.
• Extended treatment duration is crucial for achieving sustained clinical and parasitological cure.
• This study underscores the importance of adequate treatment length in pediatric parasitic infections.